Zeidan, Bashar
Manousopoulou, Antigoni
Garay-Baquero, Diana J.
White, Cory H.
Larkin, Samantha E. T.
Potter, Kathleen N.
Roumeliotis, Theodoros I.
Papachristou, Evangelia K.
Copson, Ellen
Cutress, Ramsey I.
Beers, Stephen A.
Eccles, Diana
Townsend, Paul A.
Garbis, Spiros D.
Article History
Received: 17 July 2017
Accepted: 25 January 2018
First Online: 22 March 2018
Ethics approval and consent to participate
: The study received ethical approval from the South and West Multi-centre Research Ethics Committee (MREC 00/6/69). POSH is a multicentre prospective observational cohort study of 3000 young women diagnosed with breast cancer in the UK between 2000 and 2008 (ExternalRef removed). All participating patients signed an informed consent form. The cohort was described previously and a detailed study protocol was published in 2007 [CitationRef removed, CitationRef removed].
: Not applicable.
: The authors declare that they have no competing interests. PAT would like to note he is cofounder of Karus Therapeutics Limited, sits on a number of company advisory boards and consults to help various companies but none are involved with or influenced this study.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.